SOURCE: Equity News Circuit

Equity News Circuit

February 21, 2013 08:15 ET

Free Research Reports on CHTP, CRTX, DMD and MDRX Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwire - Feb 21, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) shares soared over 160 percent on more than 27 million shares traded Wednesday. The company announced it has received written guidance from the FDA stating that Study 306B has the potential to serve as the basis for a resubmission of a Northera New Drug Application. The company plans to resubmit the Northera NDA sometime late in the second quarter.

Find out more about Chelsea Therapeutics including full access to the free equity report at: www.BedfordReport.com/CHTP

Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) shares spiked 23 percent on over 200,000 shares traded Wednesday. Chiesi Farmaceutici SpA, who owns approximately 60% of the outstanding shares of the Company's common stock, has made a proposal to take the company private. Chiesi will look to buy the shares it doesn't already own for approximately $6.40 to $6.70 per share.

Find out more about Cornerstone Therapeutics including full access to the free equity report at: www.BedfordReport.com/CRTX

Demand Media Inc. (NYSE: DMD) shares gained 7 percent on over 2.5 million shares traded Wednesday, which was nearly seven times the average daily volume. The company has reported that their Board of Directors has authorized a plan to potentially split their business into two separate public companies.

Find out more about Demand Media including full access to the free equity report at: www.BedfordReport.com/DMD

Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) shares gained 13.77 percent on nearly four times the average daily volume Wednesday to close at $12.72 a share. The company reported bookings in the fourth quarter increased 11.6 percent sequentially to $180.7 million.

Find out more about Allscripts Healthcare Solutions including full access to the free equity report at: www.BedfordReport.com/MDRX

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information